Ascentage Pharma, IPO
The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...
The year 2025 is expected to see a resurgence of IPOs due to policy changes, monetary easing, and a favorable business ...
In 2024, global and US markets saw a slight increase in IPOs. Syntax Data used its FIS classification system to analyze the ...
U.S. liquefied natural gas exporter Venture Global couldn’t have timed its initial public offering better: It comes just days ...
After what many considered a “slow” year for IPOs, January has ushered in a string of biotechs filing to go public. But 2024 ...
Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...
The company intends to raise Rs 72.30 crore via initial share sale at the upper price band. The book built issue comprises of ...
Denta Water IPO opened for subscription on January 22 and will close on January 24. The company aims to raise ₹220.50 crore ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback